StreetInsider.com News Articles

Novavax to Participate in 2026 Jefferies Global Healthcare Conference

Mon, 01 Jun 2026 16:00:00 -0400

GAITHERSBURG, Md., June 1, 2026 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX) today announced it will participate in the 2026 Jefferies Global Healthcare Conference.

Conference Details:
Fireside Chat
Date:	Thursday, June 4, 2026
Time:	10:30 – 11:00 a.m. Eastern Time
Location:	New York, NY

Recordings
A webcast of the

Novavax to Participate in 2026 Jefferies Global Healthcare Conference

Mon, 01 Jun 2026 16:00:00 -0400

GAITHERSBURG, Md., June 1, 2026 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX) today announced it will participate in the 2026 Jefferies Global Healthcare Conference.

Conference Details:
Fireside Chat
Date:	Thursday, June 4, 2026
Time:	10:30 – 11:00 a.m. Eastern Time
Location:	New York, NY

Recordings
A webcast of the

Novavax to Participate in 2026 Jefferies Global Healthcare Conference

Mon, 01 Jun 2026 16:00:00 -0400

GAITHERSBURG, Md., June 1, 2026 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX) today announced it will participate in the 2026 Jefferies Global Healthcare Conference.

Conference Details:
Fireside Chat
Date:	Thursday, June 4, 2026
Time:	10:30 – 11:00 a.m. Eastern Time
Location:	New York, NY

Recordings
A webcast of the

Novavax to Participate in 2026 Jefferies Global Healthcare Conference

Mon, 01 Jun 2026 16:00:00 -0400

GAITHERSBURG, Md., June 1, 2026 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX) today announced it will participate in the 2026 Jefferies Global Healthcare Conference.

Conference Details:
Fireside Chat
Date:	Thursday, June 4, 2026
Time:	10:30 – 11:00 a.m. Eastern Time
Location:	New York, NY

Recordings
A webcast of the

Form 144 NOVAVAX INC Filed by: Draghia-Akli Ruxandra

Wed, 27 May 2026 16:42:00 -0400

si-local-file:///var/storage/secattach/20260527/26558677.html

Form 144 NOVAVAX INC Filed by: Draghia-Akli Ruxandra

Wed, 27 May 2026 16:42:00 -0400

si-local-file:///var/storage/secattach/20260527/26558677.html

Form SCHEDULE 13D/A NOVAVAX INC Filed by: SHAH CAPITAL MANAGEMENT

Fri, 15 May 2026 08:15:00 -0400

si-local-file:///var/storage/secattach/20260515/26499939.html

Form SCHEDULE 13D/A NOVAVAX INC Filed by: SHAH CAPITAL MANAGEMENT

Fri, 15 May 2026 08:15:00 -0400

si-local-file:///var/storage/secattach/20260515/26499939.html

Form 144 NOVAVAX INC Filed by: Draghia-Akli Ruxandra

Thu, 07 May 2026 17:04:00 -0400

si-local-file:///var/storage/secattach/20260507/26455045.html

Form 144 NOVAVAX INC Filed by: Draghia-Akli Ruxandra

Thu, 07 May 2026 17:04:00 -0400

si-local-file:///var/storage/secattach/20260507/26455045.html

Novavax to Participate in BofA Securities 2026 Health Care Conference

Thu, 07 May 2026 16:00:00 -0400

GAITHERSBURG, Md., May 7, 2026 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX) today announced that it will participate in the BofA Securities 2026 Health Care Conference.

Conference Details:

Fireside Chat

Date:

Wednesday, May 13, 2026

Time:

3:00 – 3:30 p.m. Pacific Time

Location:

Novavax to Participate in BofA Securities 2026 Health Care Conference

Thu, 07 May 2026 16:00:00 -0400

GAITHERSBURG, Md., May 7, 2026 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX) today announced that it will participate in the BofA Securities 2026 Health Care Conference.

Conference Details:

Fireside Chat

Date:

Wednesday, May 13, 2026

Time:

3:00 – 3:30 p.m. Pacific Time

Location:

Novavax to Participate in BofA Securities 2026 Health Care Conference

Thu, 07 May 2026 16:00:00 -0400

GAITHERSBURG, Md., May 7, 2026 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX) today announced that it will participate in the BofA Securities 2026 Health Care Conference.

Conference Details:

Fireside Chat

Date:

Wednesday, May 13, 2026

Time:

3:00 – 3:30 p.m. Pacific Time

Location:

Novavax to Participate in BofA Securities 2026 Health Care Conference

Thu, 07 May 2026 16:00:00 -0400

GAITHERSBURG, Md., May 7, 2026 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX) today announced that it will participate in the BofA Securities 2026 Health Care Conference.

Conference Details:

Fireside Chat

Date:

Wednesday, May 13, 2026

Time:

3:00 – 3:30 p.m. Pacific Time

Location:

Novavax to Participate in BofA Securities 2026 Health Care Conference

Thu, 07 May 2026 16:00:00 -0400

GAITHERSBURG, Md., May 7, 2026 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX) today announced that it will participate in the BofA Securities 2026 Health Care Conference.

Conference Details:

Fireside Chat

Date:

Wednesday, May 13, 2026

Time:

3:00 – 3:30 p.m. Pacific Time

Location:

Novavax to Participate in BofA Securities 2026 Health Care Conference

Thu, 07 May 2026 16:00:00 -0400

GAITHERSBURG, Md., May 7, 2026 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX) today announced that it will participate in the BofA Securities 2026 Health Care Conference.

Conference Details:

Fireside Chat

Date:

Wednesday, May 13, 2026

Time:

3:00 – 3:30 p.m. Pacific Time

Location:

Novavax to Participate in BofA Securities 2026 Health Care Conference

Thu, 07 May 2026 16:00:00 -0400

GAITHERSBURG, Md., May 7, 2026 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX) today announced that it will participate in the BofA Securities 2026 Health Care Conference.

Conference Details:

Fireside Chat

Date:

Wednesday, May 13, 2026

Time:

3:00 – 3:30 p.m. Pacific Time

Location:

Novavax to Participate in BofA Securities 2026 Health Care Conference

Thu, 07 May 2026 16:00:00 -0400

GAITHERSBURG, Md., May 7, 2026 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX) today announced that it will participate in the BofA Securities 2026 Health Care Conference.

Conference Details:
Fireside Chat
Date:	Wednesday, May 13, 2026
Time:	3:00 – 3:30 p.m. Pacific Time
Location:	Novavax (NVAX) Tops Q1 EPS by 18c; offers guidance Wed, 06 May 2026 08:27:11 -0400 Novavax (NASDAQ: NVAX) reported Q1 EPS of ($0.06), $0.18 better than the analyst estimate of ($0.24). Revenue for the quarter came in at $139.51 million versus the consensus estimate of $79.31 million. GUIDANCE: Novavax sees FY2026 revenue of $230-270 million, versus the consensus of $394.3 million. For earnings history and earnings-related data on Novavax (NVAX) click here. Novavax (NVAX) Tops Q1 EPS by 18c; offers guidance Wed, 06 May 2026 08:27:11 -0400 Novavax (NASDAQ: NVAX) reported Q1 EPS of ($0.06), $0.18 better than the analyst estimate of ($0.24). Revenue for the quarter came in at $139.51 million versus the consensus estimate of $79.31 million. GUIDANCE: Novavax sees FY2026 revenue of $230-270 million, versus the consensus of $394.3 million. For earnings history and earnings-related data on Novavax (NVAX) click here. Novavax (NVAX) PT Raised to $9 at TD Cowen Wed, 06 May 2026 08:20:36 -0400 TD Cowen analyst Chris LoBianco raised the price target on Novavax (NASDAQ: NVAX) to $9.00 (from $8.00) while maintaining a Hold rating. Novavax Reports First Quarter 2026 Financial Results and Operational Highlights Wed, 06 May 2026 08:00:00 -0400 Total revenue of $140 million in the first quarter of 2026 Pfizer agreement announced in January for non-exclusive license to utilize Matrix-M^® in two infectious disease areas In April, Novavax signed a new MTA with a top 10 leading pharmaceutical company and leader in oncology to explore Matrix-M in multiple oncology and infectious disease targets In April, Novavax expanded an existing partnership with a new MTA, providing access to Matrix-M for exploration in up to nine additional identified infectious diseases In February, Novavax expanded an existing MTA with a major global pharmaceutical company to explore an additional field and signed a new Novavax Reports First Quarter 2026 Financial Results and Operational Highlights Wed, 06 May 2026 08:00:00 -0400 Total revenue of $140 million in the first quarter of 2026 Pfizer agreement announced in January for non-exclusive license to utilize Matrix-M^® in two infectious disease areas In April, Novavax signed a new MTA with a top 10 leading pharmaceutical company and leader in oncology to explore Matrix-M in multiple oncology and infectious disease targets In April, Novavax expanded an existing partnership with a new MTA, providing access to Matrix-M for exploration in up to nine additional identified infectious diseases In February, Novavax expanded an existing MTA with a major global pharmaceutical company to explore an additional field and signed a new Novavax Reports First Quarter 2026 Financial Results and Operational Highlights Wed, 06 May 2026 08:00:00 -0400 Total revenue of $140 million in the first quarter of 2026 Pfizer agreement announced in January for non-exclusive license to utilize Matrix-M^® in two infectious disease areas In April, Novavax signed a new MTA with a top 10 leading pharmaceutical company and leader in oncology to explore Matrix-M in multiple oncology and infectious disease targets In April, Novavax expanded an existing partnership with a new MTA, providing access to Matrix-M for exploration in up to nine additional identified infectious diseases In February, Novavax expanded an existing MTA with a major global pharmaceutical company to explore an additional field and signed a new Novavax Reports First Quarter 2026 Financial Results and Operational Highlights Wed, 06 May 2026 08:00:00 -0400 Total revenue of $140 million in the first quarter of 2026 Pfizer agreement announced in January for non-exclusive license to utilize Matrix-M^® in two infectious disease areas In April, Novavax signed a new MTA with a top 10 leading pharmaceutical company and leader in oncology to explore Matrix-M in multiple oncology and infectious disease targets In April, Novavax expanded an existing partnership with a new MTA, providing access to Matrix-M for exploration in up to nine additional identified infectious diseases In February, Novavax expanded an existing MTA with a major global pharmaceutical company to explore an additional field and signed a new

StreetInsider.com News Articles

Novavax to Participate in 2026 Jefferies Global Healthcare Conference

Novavax to Participate in 2026 Jefferies Global Healthcare Conference

Novavax to Participate in 2026 Jefferies Global Healthcare Conference

Novavax to Participate in 2026 Jefferies Global Healthcare Conference

Form 144 NOVAVAX INC Filed by: Draghia-Akli Ruxandra

Form 144 NOVAVAX INC Filed by: Draghia-Akli Ruxandra

Form SCHEDULE 13D/A NOVAVAX INC Filed by: SHAH CAPITAL MANAGEMENT

Form SCHEDULE 13D/A NOVAVAX INC Filed by: SHAH CAPITAL MANAGEMENT

Form 144 NOVAVAX INC Filed by: Draghia-Akli Ruxandra

Form 144 NOVAVAX INC Filed by: Draghia-Akli Ruxandra

Novavax to Participate in BofA Securities 2026 Health Care Conference

Novavax to Participate in BofA Securities 2026 Health Care Conference

Novavax to Participate in BofA Securities 2026 Health Care Conference

Novavax to Participate in BofA Securities 2026 Health Care Conference

Novavax to Participate in BofA Securities 2026 Health Care Conference

Novavax to Participate in BofA Securities 2026 Health Care Conference

Novavax to Participate in BofA Securities 2026 Health Care Conference

Novavax to Participate in BofA Securities 2026 Health Care Conference

Novavax (NVAX) Tops Q1 EPS by 18c; offers guidance

Novavax (NVAX) Tops Q1 EPS by 18c; offers guidance

Novavax (NVAX) PT Raised to $9 at TD Cowen

Novavax Reports First Quarter 2026 Financial Results and Operational Highlights

Novavax Reports First Quarter 2026 Financial Results and Operational Highlights

Novavax Reports First Quarter 2026 Financial Results and Operational Highlights

Novavax Reports First Quarter 2026 Financial Results and Operational Highlights